Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Februar 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #928

    Børen - "Gen­mab-kurs­mål sæn­kes på stri­be", det må således være den halve sandhed hvis den står 2-2

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #929

      Fint at GS. De er ved at bygge en større position op i Genmab.

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #930

        GS har så vidt jeg kan se +3% af Genmab aktier.

        1 Reply Last reply
        0
        • JørgenVarnæsJ Offline
          JørgenVarnæsJ Offline
          JørgenVarnæs
          wrote on sidst redigeret af
          #931

          GS har ikke ligefrem for vane at have et target, der ligger nord for den aktuelle kurs. Det er måske den reelle grund til deres revision...

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #932

            Omkring timing af GEN1046, så er det nærmeste vi kom i går vist JvdW svar til Verdult - https://www.fool.com/earnings/call-transcripts/2021/02/23/genmab-as-gmab-q4-2020-earnings-call-transcript/

            1 Reply Last reply
            0
            • JørgenVarnæsJ Offline
              JørgenVarnæsJ Offline
              JørgenVarnæs
              wrote on sidst redigeret af
              #933

              Her siger han, at man forventer data fra expansion cohorts, men ikke meget andet

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #934

                Jyske Banks anbefaling: https://www.proinvestor.com/investornyt/672464/genmab-jyske-bank-anbefaling-haeves-til-kob-fra-hold

                1 Reply Last reply
                0
                • C Offline
                  C Offline
                  Connecting
                  wrote on sidst redigeret af
                  #935

                  Sydbank analyser post regnskab:

                  1 Reply Last reply
                  0
                  • C Offline
                    C Offline
                    Connecting
                    wrote on sidst redigeret af
                    #936

                    https://markets.sydbank.dk/PublicationsWebHandler/Default.aspx?ID=0042061-076403

                    1 Reply Last reply
                    0
                    • JørgenVarnæsJ Offline
                      JørgenVarnæsJ Offline
                      JørgenVarnæs
                      wrote on sidst redigeret af
                      #937

                      Det ser ud til, at 2021 bliver anderledes - nu kan vi se frem til masser af read-outs og ikke kun sidde og kigge på recepttal for dara. Det bliver lidt mere som de gode gamle dage

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #938

                        yes, Genmab was always blamed to be a 'one trick pony'. So now that that is changing, we suddenly invest too much...

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #939

                          I mean, we knew the products in the pipeline, so we knew how much investment will have to go into that. So for me, higher investmenst now means bringing investments forward. So my only conclusion can be that the majority of the analysts think that Genmab is going to fast I guess?

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #940

                            It
                            is why I asked
                            @troldmanden yesterday, ‘if they would delay that 1bn for a year, so that cost would be in line with analysts expectations, would you feel better?’ Personally, I don’t understand that…

                            1 Reply Last reply
                            0
                            • JørgenVarnæsJ Offline
                              JørgenVarnæsJ Offline
                              JørgenVarnæs
                              wrote on sidst redigeret af
                              #941

                              This is one of those delightful moments, where we can put our money where out mouths are - Through the collaborations GEN has mitigated the risks of not being able to handle scale and speed in these large programs - now GEN must put up the money to make these things happen. That will hopefully be worth the investment

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #942

                                If analysts just see elevated costs - fine by me

                                1 Reply Last reply
                                0
                                • JørgenVarnæsJ Offline
                                  JørgenVarnæsJ Offline
                                  JørgenVarnæs
                                  wrote on sidst redigeret af
                                  #943

                                  Did anybody else notice the “Significant CMC investment” for both epco and GEN1046 on slide no 13 yesterday?

                                  1 Reply Last reply
                                  0
                                  • JørgenVarnæsJ Offline
                                    JørgenVarnæsJ Offline
                                    JørgenVarnæs
                                    wrote on sidst redigeret af
                                    #944

                                    In other words - we are “buying” a factory

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #945

                                      can we call it research lab please...

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #946

                                        Well, there is finally need for substantial production of molecules to feed the clinical programs

                                        1 Reply Last reply
                                        0
                                        • JørgenVarnæsJ Offline
                                          JørgenVarnæsJ Offline
                                          JørgenVarnæs
                                          wrote on sidst redigeret af
                                          #947

                                          That can’t be handled in research labs

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger